Supernus Pharmaceuticals Inc.
[WKN: A1JX3U | ISIN: US8684591089]
Aktienkurse
27,700€ -2,12%
Echtzeit-Aktienkurs Supernus Pharmaceuticals Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Top 3 Canadian Biotech Stocks

Canadas biotech sector is home to innovative companies pursuing cutting-edge therapies and medical technologies.Looking ahead into 2024, some market participants…

Terns Pharmaceuticals: Anlagevotum bestätigt

Toronto (www.aktiencheck.de) - Rating-Update: BMO Capital Markets bewertet die Aktie von Terns Pharmaceuticals Inc. (ISIN: US8808811074, WKN: A2QNWR, Ticker-Symbol: 430, NASDAQ-Symbol:…